Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company's product portfolio includes NV-387 drug candidate developed for RSV and influenza indications and has completed phase 1a/1b human clinical trial for the evaluation of safety and tolerability; NV-387 as an active ingredient of drug product formulations for the treatment of COVID infections comprising NV-CoV-2 Oral Syrup and NV-CoV-2 Oral Gummies, a semi-solid fixed-dose form, which are in phase 1a/1b human clinical trials for enabling body-weight-based dose titration as is required for pediatric treatments. It also offers NV-387 Solution for injection, infusion, and inhalation to treat severe cases that are not hospitalized and carried out by an injection; and injectable solution that delivered directly into the lungs as a fog created using portable battery operated nebulizer devices, which enables action at infection by a respiratory virus, such as coronaviruses, RSV, influenzas, human meta-pneumovirus, certain adenoviruses, and other infections, that can lead to severe pneumonia. In addition, the company develops NV-HHV-1, a skin cream for the treatment of Shingles rash, which has completed non-clinical pharmacology studies; oral drug with NV-HHV-1 as the active ingredient for the treatment of HSV-1 cold sores and HSV-2 genital ulcers; and other drug candidates in HIVCide program for the treatment of Dengue and Ebola virus, as well as provides Nanoviricide platform technology to treat various types of viruses. NanoViricides, Inc. was incorporated in 2005 and is headquartered in Shelton, Connecticut. more
Time Frame | NNVC | Sector | S&P500 |
---|---|---|---|
1-Week Return | 3.38% | -0.94% | -2.6% |
1-Month Return | 12.5% | -5.08% | -1.08% |
3-Month Return | -0.65% | -10.62% | 3.45% |
6-Month Return | -20.31% | -6.18% | 8.57% |
1-Year Return | 47.07% | 1.98% | 24.3% |
3-Year Return | -61.17% | -0.93% | 25.58% |
5-Year Return | -42.05% | 33.84% | 84.07% |
10-Year Return | -97.29% | 102.52% | 185.12% |
Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | - | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
Cost of Revenue | 699.72K | 704.54K | 723.33K | 747.53K | 759.01K | [{"date":"2020-06-30","value":92.19,"profit":true},{"date":"2021-06-30","value":92.82,"profit":true},{"date":"2022-06-30","value":95.3,"profit":true},{"date":"2023-06-30","value":98.49,"profit":true},{"date":"2024-06-30","value":100,"profit":true}] |
Gross Profit | (699.72K) | (704.54K) | (723.33K) | (747.53K) | (759.01K) | [{"date":"2020-06-30","value":-69972400,"profit":false},{"date":"2021-06-30","value":-70453800,"profit":false},{"date":"2022-06-30","value":-72332500,"profit":false},{"date":"2023-06-30","value":-74752900,"profit":false},{"date":"2024-06-30","value":-75901400,"profit":false}] |
Gross Margin | - | - | - | - | - | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
Operating Expenses | 8.00M | 8.74M | 8.11M | 8.94M | 8.52M | [{"date":"2020-06-30","value":89.41,"profit":true},{"date":"2021-06-30","value":97.77,"profit":true},{"date":"2022-06-30","value":90.72,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":95.22,"profit":true}] |
Operating Income | (8.00M) | (8.74M) | (8.11M) | (8.94M) | (8.52M) | [{"date":"2020-06-30","value":-799645900,"profit":false},{"date":"2021-06-30","value":-874410600,"profit":false},{"date":"2022-06-30","value":-811359900,"profit":false},{"date":"2023-06-30","value":-894346800,"profit":false},{"date":"2024-06-30","value":-851611100,"profit":false}] |
Total Non-Operating Income/Expense | (5.53M) | (154.14K) | 13.47K | 709.79K | 443.93K | [{"date":"2020-06-30","value":-778.63,"profit":false},{"date":"2021-06-30","value":-21.72,"profit":false},{"date":"2022-06-30","value":1.9,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":62.54,"profit":true}] |
Pre-Tax Income | (13.45M) | (8.82M) | (8.11M) | (8.59M) | (8.29M) | [{"date":"2020-06-30","value":-1344653800,"profit":false},{"date":"2021-06-30","value":-882218900,"profit":false},{"date":"2022-06-30","value":-810686300,"profit":false},{"date":"2023-06-30","value":-858857300,"profit":false},{"date":"2024-06-30","value":-829414600,"profit":false}] |
Income Taxes | (49.00K) | 85.41K | (6.74K) | 355.83K | - | [{"date":"2020-06-30","value":-13.77,"profit":false},{"date":"2021-06-30","value":24,"profit":true},{"date":"2022-06-30","value":-1.89,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
Income After Taxes | (13.40M) | (8.91M) | (8.10M) | (8.94M) | - | [{"date":"2020-06-30","value":-1339753900,"profit":false},{"date":"2021-06-30","value":-890759400,"profit":false},{"date":"2022-06-30","value":-810012700,"profit":false},{"date":"2023-06-30","value":-894440600,"profit":false},{"date":"2024-06-30","value":"-","profit":true}] |
Income From Continuous Operations | (13.45M) | (8.82M) | (8.11M) | (8.59M) | (8.29M) | [{"date":"2020-06-30","value":-1344653800,"profit":false},{"date":"2021-06-30","value":-882218900,"profit":false},{"date":"2022-06-30","value":-810686300,"profit":false},{"date":"2023-06-30","value":-858857300,"profit":false},{"date":"2024-06-30","value":-829414600,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
Net Income | (13.40M) | (8.91M) | (8.10M) | (8.59M) | (8.29M) | [{"date":"2020-06-30","value":-1339753900,"profit":false},{"date":"2021-06-30","value":-890759400,"profit":false},{"date":"2022-06-30","value":-810012700,"profit":false},{"date":"2023-06-30","value":-858857300,"profit":false},{"date":"2024-06-30","value":-829414600,"profit":false}] |
EPS (Diluted) | (2.38) | (0.81) | (0.71) | (0.74) | (0.68) | [{"date":"2020-06-30","value":-238,"profit":false},{"date":"2021-06-30","value":-81,"profit":false},{"date":"2022-06-30","value":-71,"profit":false},{"date":"2023-06-30","value":-74.15,"profit":false},{"date":"2024-06-30","value":-68,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
NNVC | |
---|---|
Cash Ratio | 2.37 |
Current Ratio | 2.48 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
NNVC | |
---|---|
ROA (LTM) | -35.81% |
ROE (LTM) | -63.00% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
NNVC | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.14 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.86 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
NNVC | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 2.11 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | NM |
PEG | NM |
NanoViricides Inc (NNVC) share price today is $1.519
Yes, Indians can buy shares of NanoViricides Inc (NNVC) on Vested. To buy NanoViricides Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NNVC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of NanoViricides Inc (NNVC) via the Vested app. You can start investing in NanoViricides Inc (NNVC) with a minimum investment of $1.
You can invest in shares of NanoViricides Inc (NNVC) via Vested in three simple steps:
The 52-week high price of NanoViricides Inc (NNVC) is $3.59. The 52-week low price of NanoViricides Inc (NNVC) is $1.
The price-to-earnings (P/E) ratio of NanoViricides Inc (NNVC) is
The price-to-book (P/B) ratio of NanoViricides Inc (NNVC) is 2.11
The dividend yield of NanoViricides Inc (NNVC) is 0.00%
The market capitalization of NanoViricides Inc (NNVC) is $18.83M
The stock symbol (or ticker) of NanoViricides Inc is NNVC